首页> 外文OA文献 >Palmitoylation of pulmonary surfactant protein SP-C is critical for its functional cooperation with SP-B to sustain compression/expansion dynamics in cholesterol-containing surfactant films
【2h】

Palmitoylation of pulmonary surfactant protein SP-C is critical for its functional cooperation with SP-B to sustain compression/expansion dynamics in cholesterol-containing surfactant films

机译:肺表面活性剂蛋白SP-C的棕榈酰化对于其与SP-B的功能合作至关重要,以维持含胆固醇的表面活性剂薄膜的压缩/膨胀动力学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recent data suggest that a functional cooperation between surfactant proteins SP-B and SP-C may be required to sustain a proper compression-expansion dynamics in the presence of physiological proportions of cholesterol. SP-C is a dually palmitoylated polypeptide of 4.2 kDa, but the role of acylation in SP-C activity is not completely understood. In this work we have compared the behavior of native palmitoylated SP-C and recombinant nonpalmitoylated versions of SP-C produced in bacteria to get a detailed insight into the importance of the palmitic chains to optimize interfacial performance of cholesterol-containing surfactant films. We found that palmitoylation of SP-C is not essential for the protein to promote rapid interfacial adsorption of phospholipids to equilibrium surface tensions (∼22 mN/m), in the presence or absence of cholesterol. However, palmitoylation of SP-C is critical for cholesterol-containing films to reach surface tensions ≤1 mN/m at the highest compression rates assessed in a captive bubble surfactometer, in the presence of SP-B. Interestingly, the ability of SP-C to facilitate reinsertion of phospholipids during expansion was not impaired to the same extent in the absence of palmitoylation, suggesting the existence of palmitoylation-dependent and -independent functions of the protein. We conclude that palmitoylation is key for the functional cooperation of SP-C with SP-B that enables cholesterol-containing surfactant films to reach very low tensions under compression, which could be particularly important in the design of clinical surfactants destined to replacement therapies in pathologies such as acute respiratory distress syndrome.
机译:最近的数据表明,在存在生理比例的胆固醇的情况下,可能需要表面活性剂蛋白SP-B和SP-C之间的功能配合以维持适当的压缩-膨胀动力学。 SP-C是4.2 kDa的双棕榈酰化多肽,但是尚不完全了解酰化在SP-C活性中的作用。在这项工作中,我们比较了细菌中产生的天然棕榈酰化SP-C和重组非棕榈酸化版本的SP-C的行为,以深入了解棕榈链对优化含胆固醇表面活性剂膜的界面性能的重要性。我们发现,在存在或不存在胆固醇的情况下,SP-C的棕榈酰化对于蛋白质促进磷脂快速界面吸附至平衡表面张力(〜22 mN / m)并不是必需的。但是,SP-C的棕榈酰化对于在SP-B存在的情况下,在俘获气泡表面张力计中评估的最高压缩率下,使含胆固醇的薄膜达到表面张力≤1 mN / m至关重要。有趣的是,在不存在棕榈酰化的情况下,SP-C促进磷脂在扩张过程中重新插入的能力没有受到相同程度的损害,这表明该蛋白存在棕榈酰化依赖性和非依赖性功能。我们得出结论,棕榈酰化是SP-C与SP-B功能合作的关键,SP-B可使含胆固醇的表面活性剂膜在压缩下达到非常低的张力,这在设计用于替代病理学疗法的临床表面活性剂的设计中可能特别重要如急性呼吸窘迫综合征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号